STAT+: Viking Therapeutics oral weight loss drug hits mark in mid-stage trial but disappoints investors
Written by
STAT News
Published
0
comments
0
min
A new oral weight loss drug developed by Viking Therapeutics hit the mark in a mid-stage clinical trial, but the side effect and discontinuation rates disappointed investors.